Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23 - Concepedia

Concepedia

Publication | Closed Access

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

275

Citations

33

References

2001

Year

Bernard Fisher, Stewart Anderson, Elizabeth Tan-Chiu, Norman Wolmark, D. Lawrence Wickerham, Edwin R. Fisher, Nikolay V. Dimitrov, James N. Atkins, Neil Abramson, Sofía D. Merajver,

Journal of Clinical Oncology

Abstract

There was no significant difference in the outcome of patients who received AC or CMF. TAM with either regimen resulted in no significant advantage over that achieved from chemotherapy alone.

References

	Year	Citations

Page 1